ArticleAging2023

Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis.

Tung-Wei Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.